According to results from this study, chromosomal deletion and truncation are the two main genomic mechanisms leading to NKAIN2 loss of function in prostate cancer, whereas mutation of NKAIN2 occurs in prostate cancer at a low frequency. The gene discussed is NKAIN2; the disease is prostate cancer.